Unique Aberrations in Intimal Sarcoma Identified by Next-Generation Sequencing as Potential Therapy Targets

por Roszik, Jason, Khan, Abir, Conley, Anthony P., Livingston, J. Andrew, Groisberg, Roman, Ravi, Vinod, Carmagnani Pestana, Roberto, Sen, Shiraj, Subbiah, Vivek
Publicado 2019

Dual inhibition of BRAF and mTOR in BRAF(V600E)-mutant pediatric, adolescent, and young adult brain tumors

por Sen, Shiraj, Tanaka, Ryuma, Khatua, Soumen, Zaky, Wafik, Janku, Filip, Penas-Prado, Marta, Weathers, Shiao-Pei, Behrang, Amini, Roszik, Jason, Subbiah, Vivek
Publicado 2020

Natural History of Human Epidermal Growth Factor Receptor 2–Amplified and Human Epidermal Growth Factor Receptor 2 Wild-Type Refractory Metastatic Colorectal Cancer in US Clinical...

por Schröder, Carsten, Gower-Page, Craig, Reyes-Rivera, Irmarie, Patel, Arisha, Price, Richard, Sen, Shiraj, Davies, Jessica, Castellanos, Emily, Snider, Jeremy, Bai, Xiaobo, Fisher, Virginia, Mhatre, Shivani K.
Publicado 2022

Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trials

por Sen, Shiraj, Hess, Kenneth, Hong, David S, Naing, Aung, Piha-Paul, Sarina, Janku, Filip, Fu, Siqing, Subbiah, Ishwaria M, Liu, Holly, Khanji, Rahil, Huang, Le, Moorthy, Shhyam, Karp, Daniel D, Tsimberidou, Apostolia, Meric-Bernstam, Funda, Subbiah, Vivek
Publicado 2018

Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas

por Groisberg, Roman, Hong, David S., Holla, Vijaykumar, Janku, Filip, Piha-Paul, Sarina, Ravi, Vinod, Benjamin, Robert, Patel, Shreyas Kumar, Somaiah, Neeta, Conley, Anthony, Ali, Siraj M., Schrock, Alexa B., Ross, Jeffrey S., Stephens, Philip J., Miller, Vincent A., Sen, Shiraj, Herzog, Cynthia, Meric-Bernstam, Funda, Subbiah, Vivek
Publicado 2017

Glucose Regulation of Load‐Induced mTOR Signaling and ER Stress in Mammalian Heart

por Sen, Shiraj, Kundu, Bijoy K., Wu, Henry Cheng‐Ju, Hashmi, S. Shahrukh, Guthrie, Patrick, Locke, Landon W., Roy, R. Jack, Matherne, G. Paul, Berr, Stuart S., Terwelp, Matthew, Scott, Brian, Carranza, Sylvia, Frazier, O. Howard, Glover, David K., Dillmann, Wolfgang H., Gambello, Michael J., Entman, Mark L., Taegtmeyer, Heinrich
Publicado 2013

Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers

por Sen, Shiraj, Kato, Shumei, Agarwal, Rishi, Piha-Paul, Sarina, Hess, Kenneth, Karp, Daniel, Janku, Filip, Fu, Siqing, Naing, Aung, Pant, Shubham, Falchook, Gerald, Tang, Chad, Wu, Xifeng, Ye, Yuanqing, Tsimberidou, Apostolia, Subbiah, Vivek, Kurzrock, Razelle, Byers, Lauren, Westin, Shannon, Lim, JoAnn, Bean, Stacie, Bass, Allison, Nguyen, Ly, Meric-Bernstam, Funda, Hong, David
Publicado 2018

Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)

por Carmagnani Pestana, Roberto, Moyers, Justin T., Roszik, Jason, Sen, Shiraj, Hong, David S., Naing, Aung, Herzog, Cynthia E., Fu, Siqing, Piha-Paul, Sarina A., Rodon, Jordi, Yap, Timothy A., Karp, Daniel D., Tsimberidou, Apostolia M., Pant, Shubham, Zarzour, Maria A., Ratan, Ravin, Ravi, Vinod, Benjamin, Robert S., Lazar, Alexander J., Wang, Wei-Lien, Daw, Najat, Gill, Jonathan B., Harrison, Douglas J., Lewis, Valerae O., Roland, Christina L., Patel, Shreyaskumar R., Livingston, J. Andrew, Somaiah, Neeta, Ludwig, Joseph A., Conley, Anthony P., Hamerschlak, Nelson, Gorlick, Richard, Meric-Bernstam, Funda, Subbiah, Vivek
Publicado 2023